Statements (28)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
alpha-2 adrenergic agonist |
gptkbp:ATCCode |
QN05CM91
|
gptkbp:CASNumber |
86347-14-0
|
gptkbp:discoveredBy |
1980s
|
gptkbp:eliminationHalfLife |
1.2 hours (cat)
1–2 hours (dog) |
gptkbp:enemyOf |
atipamezole
|
gptkbp:hasMolecularFormula |
C13H16N2
|
https://www.w3.org/2000/01/rdf-schema#label |
medetomidine
|
gptkbp:IUPACName |
(±)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
|
gptkbp:legalStatus |
veterinary use only
|
gptkbp:meltingPoint |
186–188 °C
|
gptkbp:PubChem_CID |
gptkb:CHEMBL1092
71194 64313 |
gptkbp:relatedTo |
gptkb:dexmedetomidine
|
gptkbp:routeOfAdministration |
intramuscular
intravenous |
gptkbp:sideEffect |
hypotension
bradycardia |
gptkbp:synonym |
Domitor
|
gptkbp:UNII |
3XMK78S47O
|
gptkbp:used_in |
gptkb:veterinary_medicine
|
gptkbp:usedFor |
analgesic
sedative |
gptkbp:bfsParent |
gptkb:dexmedetomidine
|
gptkbp:bfsLayer |
7
|